(Q43130748)

14 November 2017

title

Ammonia toxicity to the brain: effects on creatine metabolism and transport and protective roles of creatine (English)

1 reference

14 November 2017

0 references

Olivier Braissant

1

1 reference

14 November 2017

publication date

14 February 2010

1 reference

Molecular Genetics and Metabolism

14 November 2017

published in

1 reference

14 November 2017

volume

100 Suppl 1

1 reference

14 November 2017

page(s)

S53-8

1 reference

Hyperammonemia-induced toxicity for the developing central nervous system

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Neurologic damage and neurocognitive dysfunction in urea cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Cross-sectional multicenter study of patients with urea cycle disorders in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Neurological implications of urea cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Survival after treatment with phenylacetate and benzoate for urea-cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Mechanisms of hyperammonemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Long-term outcome of patients with urea cycle disorders and the question of neonatal screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Current concepts in the pathogenesis of urea cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Hyperammonemia: regulation of argininosuccinate synthetase and argininosuccinate lyase genes in aggregating cell cultures of fetal rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Ammonia toxicity to the brain and creatine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Nitric oxide in hepatic encephalopathy and hyperammonemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Ammonium-induced impairment of axonal growth is prevented through glial creatine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Ammonium alters creatine transport and synthesis in a 3D culture of developing brain cells, resulting in secondary cerebral creatine deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

The neuroprotective role of creatine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Creatine and creatinine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Creatine: endogenous metabolite, dietary, and therapeutic supplement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Creatine synthesis: production of guanidinoacetate by the rat and human kidney in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Creatine synthesis: hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Distribution of creatine, guanidinoacetate and the enzymes for their biosynthesis in the animal kingdom. Implications for phylogeny

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Evidence for creatine biosynthesis in Müller glia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Blood-to-retina transport of creatine via creatine transporter (CRT) at the rat inner blood-retinal barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Creatine transporter localization in developing and adult retina: importance of creatine to retinal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Expression and possible role of creatine transporter in the brain and at the blood-cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Immunohistochemical localisation of the creatine transporter in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Spatiotemporal expression of the creatine metabolism related genes agat, gamt and ct1 during zebrafish embryogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Brain creatine phosphate and creatine kinase in mice fed an analogue of creatine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Creatine kinase isoenzymes in chicken cerebellum: specific localization of brain-type creatine kinase in Bergmann glial cells and muscle-type creatine kinase in Purkinje neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Guanidino compounds that are increased in hyperargininemia inhibit GABA and glycine responses on mouse neurons in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Activation of GABA(A) receptors by guanidinoacetate: a novel pathophysiological mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Endogenous guanidino compounds as uremic neurotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Activation of cerebellar granule cells GABA(A) receptors by guanidinoacetate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Exocytotic release of creatine in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Hypo-osmotic swelling-activated release of organic osmolytes in brain slices: implications for brain oedema in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Swelling-activated taurine and creatine effluxes from rat cortical astrocytes are pharmacologically distinct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Hyperammonemia induces transport of taurine and creatine and suppresses claudin-12 gene expression in brain capillary endothelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Possible role of creatine concentrations in the brain in regulating appetite and weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Ornithine carbamoyl transferase deficiency: findings, models and problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Dendritic alterations in cortical pyramidal cells in the sparse fur mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Activation of NMDA receptor mediates the toxicity of ammonia and the effects of ammonia on the microtubule-associated protein MAP-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Morphometry of astrocyte and oligodendrocyte ultrastructure after portocaval anastomosis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Effects of hyperammonaemia on brain function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Mechanisms of ammonia-induced astrocyte swelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Kinetics of creatine in blood and brain after intraperitoneal injection in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Creatine transport in cultured cells of rat and mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

Expression and function of AGAT, GAMT and CT1 in the mammalian brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMGME.2010.02.011

1 reference

14 November 2017

1 reference